Zhen Bo Su
Directeur/Bestuurslid bij CASI PHARMACEUTICALS, INC.
Profiel
Mr. Zhen Bo Su is an Independent Director at CASI Pharmaceuticals, Inc., a Managing Partner at Shenzhen Share Investment LP and a Partner at Redhill Capital Investment Management Co. Ltd.
He is on the Board of Directors at CASI Pharmaceuticals, Inc. and Shenzhen Share Investment LP.
Mr. Su was previously employed as a Co-Founder by Chongqing TCR CURE Biopharma Technology Co., Ltd.
He received his undergraduate degree from Guangdong Medical University, a graduate degree from Sun Yat-Sen University and an MBA from The University of Chicago.
Actieve functies van Zhen Bo Su
| Bedrijven | Functie | Begin |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 21-03-2023 |
Shenzhen Share Investment LP
 Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Directeur/Bestuurslid | - |
| Redhill Capital Investment Management Co. Ltd. | Corporate Officer/Principal | - |
Eerdere bekende functies van Zhen Bo Su
| Bedrijven | Functie | Einde |
|---|---|---|
Chongqing TCR CURE Biopharma Technology Co., Ltd
 Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Oprichter | - |
Opleiding van Zhen Bo Su
| Guangdong Medical University | Undergraduate Degree |
| Sun Yat-Sen University | Graduate Degree |
| The University of Chicago | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CASI PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Shenzhen Share Investment LP
Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Finance |
Chongqing TCR CURE Biopharma Technology Co., Ltd
Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Health Technology |
| Redhill Capital Investment Management Co. Ltd. |